On January 9 - 14, the 2nd session of the 16th Qingdao People's Congress was held in the People's Hall of Qingdao. Shouldering the trust of the Qingdao people, the deputies to the Qingdao People's Congress from all walks of life in Qingdao attended the meeting to fulfill the sacred duties conferred by the Constitution and laws. As a deputy to the Qingdao People's Congress, President Fu Gang of the BAHEAL Pharmaceutical Group, centering on the spirit of the government work report, spoke glowingly

On January 9, the BAHEAL Intelligent Technology, a subsidiary of the BAHEAL Pharmaceutical Group, formally signed a cooperation agreement in Beijing with TopGene. Both parties will integrate resources and effectively promote the landing and development of Watson for Genomics (Watson Gene Solutions, hereinafter referred to as WfG) in China so as to boost the presence of the WfG in all the cities covered by the TopGene. With the reach of the cooperation between the two parties, it also means that

Qingdao Baheal Pharmaceutical Ltd. recently announced that, its advanced generics preparation technology has achieved major breakthrough, and Nida, an osmotic-controlled metformin-based diabetes medicine has been approved by FDA to come into the market, which will bring benefits to patients with type-2 diabetes, particularly, those patients accompanied with obesity and hyperinsulinemia.

The Meeting for promoting and introducing the Fund for Replacing Old Growth Drivers with New Ones in Qingdao and the Venture Capital Investment Summit Forum were held in the Jinjialing Financial District of Qingdao, Shandong Province on April 20, 2018. Meng Fanli, Mayor of Qingdao and deputy secretary of the Municipal Committee of the Communist Party of China attended the event and pointed out that a RMB 300 billion fund has been set up to channel financing and social capital into key projects and fields for the replacement of old driving forces with new ones. It is part of a major project to accelerate the replacement of old driving forces with new ones in Qingdao, he said.

A sum-up meeting was held in Beijing recently for a project on improving Watson for Oncology initiated by IMB together with BAHEAL Intelligent Technology.